Ken Fisher Catalent, Inc. Transaction History

Fisher Asset Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 12, 2020	SELL	$47.06 - $56.64 $5.16 Million - $6.21 Million	-109,719 Closed	0 $0
Q3 2019 Oct 29, 2019	BUY	$47.45 - $58.05 $4.63 Million - $5.67 Million	97,595 Added 804.97%	109,719 $5.23 Million
Q1 2018 Apr 19, 2018	BUY	$39.4 - $47.39 $477,685 - $574,556	12,124 New	12,124 $498,000

484

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Fisher Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Fisher Asset Management, LLC and Ken Fisher with notifications on news.